HCA Healthcare, Inc. $HCA Shares Sold by First Eagle Investment Management LLC

First Eagle Investment Management LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,646,152 shares of the company’s stock after selling 273,320 shares during the quarter. HCA Healthcare comprises about 3.0% of First Eagle Investment Management LLC’s investment portfolio, making the stock its 6th largest position. First Eagle Investment Management LLC’s holdings in HCA Healthcare were worth $1,702,243,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $26,000. Holos Integrated Wealth LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $29,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $31,000. JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $34,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,714 shares of company stock worth $7,050,460 in the last 90 days. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Down 2.0%

NYSE:HCA opened at $426.58 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a market cap of $94.63 billion, a P/E ratio of 14.67, a price-to-earnings-growth ratio of 1.38 and a beta of 1.18. The business has a 50 day moving average price of $487.44 and a two-hundred day moving average price of $486.55.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 EPS. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HCA shares. Mizuho boosted their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, KeyCorp reduced their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $517.82.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.